Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Johnson and Johnson
Harvard Business School

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050706

« Back to Dashboard

NDA 050706 describes MERREM, which is a drug marketed by Pfizer and is included in one NDA. It is available from one supplier. Additional details are available on the MERREM profile page.

The generic ingredient in MERREM is meropenem. There are thirty-one drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the meropenem profile page.

Summary for 050706

Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 050706


Suppliers and Packaging for NDA: 050706

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MERREM meropenem INJECTABLE;INJECTION 050706 NDA AstraZeneca Pharmaceuticals LP 0310-0321 0310-0321-30 10 VIAL in 1 CARTON (0310-0321-30) > 30 mL in 1 VIAL
MERREM meropenem INJECTABLE;INJECTION 050706 NDA AstraZeneca Pharmaceuticals LP 0310-0325 0310-0325-20 10 VIAL in 1 CARTON (0310-0325-20) > 20 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1GM/VIAL
Approval Date:Jun 21, 1996TE:APRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/VIAL
Approval Date:Jun 21, 1996TE:APRLD:Yes

Expired Orange Book Patents for NDA: 050706

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
PfizerMERREMmeropenemINJECTABLE;INJECTION050706-001Jun 21, 1996► Subscribe► Subscribe
PfizerMERREMmeropenemINJECTABLE;INJECTION050706-003Jun 21, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo
Cantor Fitzgerald
Queensland Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: